Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. American CryoStem Corporation
483
•American CryoStem Corporation•July 26, 2017

American CryoStem Corporation – FDA 483, Jul 26, 2017

Record Details

This FDA Form 483 details observations from an inspection of a facility manufacturing stromal vascular fraction (SVF) and ATCell expanded mesenchymal stem cells (MSCs) biological drug products, with approximately (b)(4) batches of ATCell distributed since 2011.

Key violations include: 1. **Lack of Sterilization Process Validation:** Procedures to prevent microbiological contamination of sterile drug products do not include validation of aseptic processes for SVF isolation and MSC expansion. 2. **Absence of Process Validation:** No written procedures for production and process controls ensure drug product identity, strength, quality, and purity, as manufacturing processes for SVF and ATCell have not been validated. 3. **Deficient Environmental Monitoring:** A program for environmental monitoring for microorganisms in aseptic processing areas has not been established since operations began in 2011. 4. **Inadequate Component Supplier Reliability Validation:** Reliability of component suppliers' analyses (e.g., for (b)(4) and (b)(4)) is deficient, lacking at least one specific identity test and appropriate validation of supplier test results. 5. **Missing Component Sampling and Testing Procedures:** No written procedures exist for sampling and testing upon receipt of manufacturing components like (b)(4) and (b)(4). 6. **No Drug Product Stability Testing Program:** A written program to assess drug product stability characteristics is absent. 7. **Unvalidated Cleaning

Company
American CryoStem Corporation
Inspection date
July 26, 2017
Product type
Devices
Office
Florida District Office
People
  • Cody D. Rickman
  • Kip J. Hanks (Consumer Safety)
View Company Profile

ID · ee687377-6a85-4653-94ef-fee366e2256c

Violation Codes9
21 CFR 211.113(b)21 CFR 211.100(a)21 CFR 211.160(b)21 CFR 211.84(d)(2)21 CFR 211.166(a)21 CFR 211.42(c)(10)(v)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(a)21 CFR 211.113(c)

Full citation text and observation details available on the Dashboard.

Other documents for American CryoStem Corporation
  • 483 - 2024-05-22May 22, 2024
  • WARNING_LETTER - 2017-07-26July 26, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore American CryoStem Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.